Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Myo-inositol is a naturally occurring carbocyclic sugar and the most abundant form of inositol found in nature. It is sometimes referred to as vitamin B8 (though it is not a true vitamin) and plays a key role as a structural basis for secondary messengers involved in signal transduction for hormones such as insulin and neurotransmitters. Myo-inositol acts as an important growth-promoting factor for mammalian cells and animals[8]. It mediates signal transduction by participating in the formation of phosphatidylinositol phosphates that regulate cellular processes including cell growth, survival, and metabolism[6][8]. As a supplement or drug ingredient, myo-inositol has been used primarily to improve insulin sensitivity (notably in polycystic ovary syndrome), metabolic syndrome, gestational diabetes mellitus prevention/treatment[4][5], fertility enhancement (especially for women with PCOS), diabetic neuropathy, depression, panic disorder[5], Alzheimer's disease[5], and other conditions. Its mechanism includes improving insulin signaling pathways and modulating glucose uptake at the cellular level[4][6]. Myo-inositol is available over-the-counter as a dietary supplement.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on myo-inositol.